This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2023 Mar;22(3):174.

doi: 10.1038/d41573-023-00029-5.

Trends in the global antibiotics market

Jacob Madden, Kevin Outterson

PMID: 36792692
DOI: 10.1038/d41573-023-00029-5

Trends in the global antibiotics market

Jacob Madden et al. Nat Rev Drug Discov. 2023 Mar.

. 2023 Mar;22(3):174.

doi: 10.1038/d41573-023-00029-5.

Authors

Jacob Madden, Kevin Outterson

PMID: 36792692
DOI: 10.1038/d41573-023-00029-5

No abstract available

PubMed Disclaimer

Similar articles

The antibiotics market.
Hamad B. Hamad B. Nat Rev Drug Discov. 2010 Sep;9(9):675-6. doi: 10.1038/nrd3267. Nat Rev Drug Discov. 2010. PMID: 20811374 No abstract available.
Availability of injectable antibiotics in a town market in southwest Cameroon.
Becker J, Drucker E, Enyong P, Marx P. Becker J, et al. Lancet Infect Dis. 2002 Jun;2(6):325-6. doi: 10.1016/s1473-3099(02)00285-2. Lancet Infect Dis. 2002. PMID: 12144894 No abstract available.
Market concentration of new antibiotic sales.
Rahman S, Lindahl O, Morel CM, Hollis A. Rahman S, et al. J Antibiot (Tokyo). 2021 Jun;74(6):421-423. doi: 10.1038/s41429-021-00414-5. Epub 2021 Mar 4. J Antibiot (Tokyo). 2021. PMID: 33664435
Antibiotic development: a victim of market forces?
Tillotson GS. Tillotson GS. IDrugs. 2008 May;11(5):340-6. IDrugs. 2008. PMID: 18465675 Review.
Resistance diagnosis and the changing economics of antibiotic discovery.
McAdams D. McAdams D. Ann N Y Acad Sci. 2017 Jan;1388(1):18-25. doi: 10.1111/nyas.13303. Epub 2017 Jan 10. Ann N Y Acad Sci. 2017. PMID: 28072904 Review.

See all similar articles

Cited by

A Review of Antibacterial Candidates with New Modes of Action.
Butler MS, Vollmer W, Goodall ECA, Capon RJ, Henderson IR, Blaskovich MAT. Butler MS, et al. ACS Infect Dis. 2024 Oct 11;10(10):3440-3474. doi: 10.1021/acsinfecdis.4c00218. Epub 2024 Jul 17. ACS Infect Dis. 2024. PMID: 39018341 Free PMC article. Review.
Antibiotics in the clinical pipeline as of December 2022.
Butler MS, Henderson IR, Capon RJ, Blaskovich MAT. Butler MS, et al. J Antibiot (Tokyo). 2023 Aug;76(8):431-473. doi: 10.1038/s41429-023-00629-8. Epub 2023 Jun 8. J Antibiot (Tokyo). 2023. PMID: 37291465 Free PMC article. Review.
Current economic and regulatory challenges in developing antibiotics for Gram-negative bacteria.
Gargate N, Laws M, Rahman KM. Gargate N, et al. NPJ Antimicrob Resist. 2025 Jun 11;3(1):50. doi: 10.1038/s44259-025-00123-1. NPJ Antimicrob Resist. 2025. PMID: 40500291 Free PMC article. Review.
A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeae.
Uehara T, Zulli AL, Miller B, Avery LM, Boyd SA, Chatwin CL, Chu GH, Drager AS, Edwards M, Emeigh Hart SG, Myers CL, Rongala G, Stevenson A, Uehara K, Yi F, Wang B, Liu Z, Wang M, Zhao Z, Zhou X, Zhao H, Stratton CM, Bala S, Davies C, Tkavc R, Jerse AE, Pevear DC, Burns CJ, Daigle DM, Condon SM. Uehara T, et al. bioRxiv [Preprint]. 2024 Dec 27:2024.12.27.630553. doi: 10.1101/2024.12.27.630553. bioRxiv. 2024. PMID: 39763734 Free PMC article. Preprint.
LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases.
Bhattacharjya S, Zhang Z, Ramamoorthy A. Bhattacharjya S, et al. Biomolecules. 2024 Mar 8;14(3):320. doi: 10.3390/biom14030320. Biomolecules. 2024. PMID: 38540740 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information